These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33932914)

  • 1. Towards homogenization of liquid plug distribution in reconstructed 3D upper airways of the preterm infant.
    Elias-Kirma S; Artzy-Schnirman A; Sabatan H; Dabush C; Waisman D; Sznitman J
    J Biomech; 2021 Jun; 122():110458. PubMed ID: 33932914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-dimensional model of surfactant replacement therapy.
    Filoche M; Tai CF; Grotberg JB
    Proc Natl Acad Sci U S A; 2015 Jul; 112(30):9287-92. PubMed ID: 26170310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rat lung model of instilled liquid transport in the pulmonary airways.
    Cassidy KJ; Bull JL; Glucksberg MR; Dawson CA; Haworth ST; Hirschl R; Gavriely N; Grotberg JB
    J Appl Physiol (1985); 2001 May; 90(5):1955-67. PubMed ID: 11299290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of surfactant replacement therapy for preterm neonates with respiratory distress syndrome in low- and middle-income countries: a systematic review.
    Sankar MJ; Gupta N; Jain K; Agarwal R; Paul VK
    J Perinatol; 2016 May; 36 Suppl 1(Suppl 1):S36-48. PubMed ID: 27109091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Quantitative Study of Transport of Surfactant Boli in a Three-Dimensional Lung Model of Neonates.
    Combs H; Shark T; Heiss J; Raessi M; Tavana H
    J Biomech Eng; 2023 Feb; 145(2):. PubMed ID: 36056568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ventilation rate on instilled surfactant distribution in the pulmonary airways of rats.
    Anderson JC; Molthen RC; Dawson CA; Haworth ST; Bull JL; Glucksberg MR; Grotberg JB
    J Appl Physiol (1985); 2004 Jul; 97(1):45-56. PubMed ID: 14990558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Background to neonatal respiratory distress syndrome and treatment with exogenous surfactant.
    Robertson B
    Dev Pharmacol Ther; 1989; 13(2-4):159-63. PubMed ID: 2692998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surfactant replacement therapy for preterm and term neonates with respiratory distress.
    Polin RA; Carlo WA; ;
    Pediatrics; 2014 Jan; 133(1):156-63. PubMed ID: 24379227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate.
    Engle WA;
    Pediatrics; 2008 Feb; 121(2):419-32. PubMed ID: 18245434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surfactant therapy: past, present and future.
    Speer CP; Sweet DG; Halliday HL
    Early Hum Dev; 2013 Jun; 89 Suppl 1():S22-4. PubMed ID: 23809343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome.
    Pfister RH; Soll RF; Wiswell T
    Cochrane Database Syst Rev; 2007 Oct; (4):CD006069. PubMed ID: 17943881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surfactant-replacement therapy for respiratory distress syndrome in the preterm and term neonate: congratulations and corrections.
    Moya F; Sinha S; D'Agostino RB
    Pediatrics; 2008 Jun; 121(6):1290-1; author reply 1291-2. PubMed ID: 18519504
    [No Abstract]   [Full Text] [Related]  

  • 13. Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome.
    Pfister RH; Soll RF; Wiswell T
    Cochrane Database Syst Rev; 2007 Jul; (3):CD006069. PubMed ID: 17636826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surfactant replacement therapy in developing countries.
    Vidyasagar D; Velaphi S; Bhat VB
    Neonatology; 2011; 99(4):355-66. PubMed ID: 21701209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surfactant replacement in neonatal and adult respiratory distress syndrome.
    Robertson B
    Eur J Anaesthesiol; 1984 Dec; 1(4):335-43. PubMed ID: 6549536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Intratracheal Administration of Corticosteroid and Pulmonary Surfactant for Preventing Bronchopulmonary Dysplasia in Preterm Infants with Neonatal Respiratory Distress Syndrome: A Meta-analysis.
    Zhong YY; Li JC; Liu YL; Zhao XB; Male M; Song DK; Bai Y
    Curr Med Sci; 2019 Jun; 39(3):493-499. PubMed ID: 31209823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of surfactant therapy for respiratory distress syndrome: past, present, and future.
    Sardesai S; Biniwale M; Wertheimer F; Garingo A; Ramanathan R
    Pediatr Res; 2017 Jan; 81(1-2):240-248. PubMed ID: 27706130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surfactant replacement in the management of the neonatal respiratory distress syndrome.
    Robertson B
    Eur J Respir Dis Suppl; 1987; 153():242-8. PubMed ID: 3322864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exogenous surfactant treatments for neonatal respiratory distress syndrome and their potential role in the adult respiratory distress syndrome.
    Merritt TA; Hallman M; Spragg R; Heldt GP; Gilliard N
    Drugs; 1989 Oct; 38(4):591-611. PubMed ID: 2684594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein-containing synthetic surfactant versus protein-free synthetic surfactant for the prevention and treatment of respiratory distress syndrome.
    Pfister RH; Soll R; Wiswell TE
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006180. PubMed ID: 19821357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.